SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001078782-12-001837
Filing Date
2012-07-20
Accepted
2012-07-20 21:20:15
Documents
1
Period of Report
2012-06-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 10685
  Complete submission text file 0001078782-12-001837.txt   12478
Mailing Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075
Business Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075 858-433-2800
Imprimis Pharmaceuticals, Inc. (Issuer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1302 WAUGH DRIVE STE 618 HOUSTON TX 77019
Business Address 1302 WAUGH DRIVE STE 618 HOUSTON TX 77019 8584054448
DERMASTAR INTERNATIONAL, LLC (Reporting) CIK: 0001539513 (see all company filings)

State of Incorp.: NV | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-52998 | Film No.: 12973307